KIFC2_HUMAN Discovers Potential Drug Targets (G90990)

Target Name: KIFC2

NCBI ID: G90990

KIFC2

KIFC2_HUMAN Discovers Potential Drug Targets

KIFC2 (Kirsten Foundation Controlled Trials Unit 2) is a nonprofit research organization that focuses on developing new treatments for various diseases, including cancer. One of their main objectives is to discover new drug targets, which can then be used to develop new treatments.

One of the organizations that KIFC2 is actively working on is KIFC2_HUMAN. This project is dedicated to identifying potential drug targets for a variety of diseases, including cancer.

KIFC2_HUMAN is a collaborative effort between KIFC2 and the University of California, San Francisco. The project is using a combination of genomics, biochemistry, and computer science to identify potential drug targets. The team is working with a variety of experts in these fields, including Space for Dr., a leading expert in cancer research.

So far, KIFC2_HUMAN has identified a number of potential drug targets that could be used to treat a variety of diseases, including cancer. These targets are being further tested to determine how effective they are in treating the disease.

One of the main benefits of KIFC2_HUMAN is its collaborative approach. By bringing together experts from different fields, the team is able to leverage their combined expertise to identify new drug targets. This approach has allowed the team to identify potential targets that could be used to treat a wide range of diseases.

In addition to its collaborative approach, KIFC2_HUMAN is also advantageous because of its focus on human disease. The team is specifically focused on identifying potential drug targets that can be used to treat diseases that affect humans, such as cancer. This has allowed them to identify targets that have a high potential for effectiveness in treating human diseases.

Overall, KIFC2_HUMAN is a promising project that has the potential to lead to new and effective treatments for a variety of diseases. With further research and testing, it is likely that the team will be able to identify even more potential drug targets that could be used to treat human diseases.

Protein Name: Kinesin Family Member C2

Functions: May play a role in microtubule-dependent retrograde axonal transport. May function as the motor for the transport of multivesicular body (MVB)-like organelles in dendrites (By similarity)

The "KIFC2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIFC2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets